https://www.fiercebiotech.com/biotech/lilly-gives-60m-to-merus-ties-1-6b-biobucks-for-next-gen-cancer-research-pact
Eli Lilly, via its Loxo Oncology biotech unit, is signing up to a three-therapy deal with Merus focused on T-cell redirecting bispecific antibody work.
lillygivesmerusties
https://www.fiercebiotech.com/biotech/boehringer-okays-100m-biobuck-deal-hearing-loss-rd-project
Boehringer Ingelheim has come sweeping down into Oklahoma to land rights to a treatment for the most common type of permanent hearing loss, joining up with...
hearing lossboehringeroksbiobucksdeal